US-UK drug deal could result in 229,000 excess deaths in England, analysis suggests
Analysis of the UK-US drug trade deal indicates it could lead to approximately 229,000 excess deaths in England due to NHS funding being diverted to pay for expensive new medicines. The deal aims to ease tariffs on British drug exports to the US but raises critical health and economic concerns.
UK-US trade deal NHS medicine exports healthcare excess deaths
Linked Entities
Contributing Articles
Barcelona registers highest temperature in 112 years as UK health service urges children and elderly to ‘take weather seriously’ – Europe live
The Guardian —
Novo teste detecta câncer bucal em 1 hora e pode evitar mais de 90% das biópsias desnecessárias
Globo —
‘They said: wear angelic white’: British women who accused US airman of rape tell of American military trial
The Guardian —
UK has ‘no future’ if it fails to act on ecosystem collapse threatening national security
The Guardian —
Eight Palestinians killed in Gaza over past 24 hours
Middle East Eye —
The CLOUD Act: NHS data must be safeguarded from US interests
BMJ News —
Measles: GP catch-up vaccination campaign starts after two deaths in six months
BMJ News —
The Dungannon group using sport to help men of all ages
Yahoo Sports —
Unions in Europe press for new worker protections to counter heat stress
The Guardian —
Disability benefits in England and Wales not fit for purpose, Timms review to find
The Guardian —